RR
Ramesh Ratilal Choksi
About Ramesh Ratilal Choksi
Data last updated:
Ramesh Ratilal Choksi is a Whole-Time Director at Cadila Pharmaceuticals Limited (since 2014), Director at Irm Private Limited (since 2017) and Director at Irm Enterprises Private Limited (since 2019), and holds 8 more current directorships. The companies operate in Pharma, Agriculture and Energy and Power. The 10 current companies with reported revenue have a combined latest revenue of ₹4,376 Cr; the largest is Cadila Pharmaceuticals Limited at ₹3,869 Cr (FY 2025). Earlier, Ramesh Ratilal Choksi was a Director at Apollo Hospitals International Limited (2019–2026) and Director at Casil Industries Limited (from 2014) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cadila Pharmaceuticals Limited U24231GJ1991PLC015132 | Whole-Time Director | 07 Feb 2014 | 1991 | ₹3,869 Cr (FY 2025) | Active |
 Irm Private Limited U74120GJ1994PTC023239 | Director | 29 Jul 2017 | 1994 | ₹307 Cr (FY 2025) | Active |
 Irm Enterprises Private Limited U74110GJ2009PTC058116 | Director | 27 Sep 2019 | 2009 | ₹152 Cr (FY 2025) | Active |
 Cpl Pharmaceuticals Private Limited U24299GJ2021PTC119244 | Director | 01 Jan 2021 | 2021 | ₹38.02 Cr (FY 2025) | Active |
 Cpl Biologicals Private Limited U01403GJ2009PTC056409 | Director | 03 Nov 2018 | 2009 | ₹8.01 Cr (FY 2025) | Active |
 Gig - Irm Glass Insulators Private Limited U26952GJ2019PTC109613 | Nominee Director | 26 Apr 2024 | 2019 | ₹1.57 Cr (FY 2025) | Active |
| Cpl Infrastructure Private Limited U45209GJ2008PTC055133 | Director | 13 Jul 2022 | 2008 | ₹24.4 Lakh (FY 2025) | Active |
| Inverika Bioresearch Private Limited U73100GJ2012PTC070636 | Director | 16 Mar 2022 | 2012 | ₹20.1 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Apollo Hospitals International Limited U85110TN1997PLC039016 | Director | 19 Jan 2019 | 1997 | ₹341 Cr (FY 2025) | Active |
| Casil Industries Limited U24230GJ2012PLC071212 | Director | 07 Oct 2014 | 2012 | Amalgamated | |
| Casil Industries Limited U24231GJ2000PLC038320 | Additional Director | 02 Jun 2013 | 2000 | Amalgamated | |
 Karnavati Engineering Private Limited U29199GJ1981PTC004488 | Director | 27 Sep 2019 | 1981 | ₹6.2 Lakh (FY 2020) | Amalgamated |
| Casil Health Products Private Limited U51909GJ1995PLC027839 | Director | 21 Dec 2016 | 1995 | ₹1.54 Cr (FY 2020) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ramesh Ratilal Choksi
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramesh Ratilal Choksi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramesh Ratilal Choksi
Ramesh Ratilal Choksi currently holds 11 directorships: Cadila Pharmaceuticals Limited (Whole-Time Director, since 07 Feb 2014, revenue ₹3,869 Cr (FY 2025)); Irm Private Limited (Director, since 29 Jul 2017, revenue ₹307 Cr (FY 2025)); Irm Enterprises Private Limited (Director, since 27 Sep 2019, revenue ₹152 Cr (FY 2025)); Cpl Pharmaceuticals Private Limited (Director, since 01 Jan 2021, revenue ₹38.02 Cr (FY 2025)); Cpl Biologicals Private Limited (Director, since 03 Nov 2018, revenue ₹8.01 Cr (FY 2025)); and 6 more.
Ramesh Ratilal Choksi was first appointed on 02 Jun 2013 as Additional Director at Casil Industries Limited. The most recent appointment on record is 26 Apr 2024 at Gig - Irm Glass Insulators Private Limited.
The 10 current companies of Ramesh Ratilal Choksi that report revenue have a combined latest revenue of ₹4,376 Cr: Cadila Pharmaceuticals Limited ₹3,869 Cr (FY 2025); Irm Private Limited ₹307 Cr (FY 2025); Irm Enterprises Private Limited ₹152 Cr (FY 2025); Cpl Pharmaceuticals Private Limited ₹38.02 Cr (FY 2025); Cpl Biologicals Private Limited ₹8.01 Cr (FY 2025); and 5 more.
Ramesh Ratilal Choksi held 5 earlier board appointments: Apollo Hospitals International Limited (Director, 19 Jan 2019 to 29 Jan 2026); Casil Industries Limited (Director, from 07 Oct 2014); Casil Industries Limited (Additional Director, from 02 Jun 2013); Karnavati Engineering Private Limited (Director, from 27 Sep 2019); Casil Health Products Private Limited (Director, from 21 Dec 2016).
The current boards of Ramesh Ratilal Choksi's companies include Girdhar Prem Balwani (Cadila Pharmaceuticals Limited), Kamlesh Navaratnalal Shah (Cadila Pharmaceuticals Limited), Parul Nikunj Shah (Cadila Pharmaceuticals Limited), Rajiv Indravadan Modi (Cadila Pharmaceuticals Limited), Rajiv Rajiv Modi (Cadila Pharmaceuticals Limited), Renuka Anjanikumar Upadhyay (Cadila Pharmaceuticals Limited), among others.